Patterns of response and progression to immunotherapy may differ from those observed with
drugs such as chemotherapy and molecularly targeted agents. Specifically, some patients …

The survival rate for metastatic osteosarcoma has not improved for several decades, since
the introduction and refinement of chemotherapy as a treatment in addition to surgery. Over …

The response evaluation criteria in solid tumours (RECIST) was developed in the late 1990s
to replace the WHO criteria for response evaluation. The new criteria included important …

Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumors known as
gliomas. They proliferate and invade extensively and yield short life expectancies despite …

Background: Objective tumor response is a common endpoint in daily practice as well as in
clinical trials to evaluate the efficacy of anti-cancer agents. Traditionally, the standard World …

Gliomas are highly invasive primary brain tumors, accounting for nearly 50% of all brain
tumors (Alvord and Shaw in The pathology of the aging human nervous system. Lea & …

Deep learning has emerged as a powerful tool for medical image analysis and diagnosis,
demonstrating high performance on tasks such as cancer detection. This literature review …

Objective response assessment is important to describe the treatment effect of anticancer
drugs. Standardization by using a “common language” is also important for comparison of …

Abstract In Canada and Europe, yttrium-90 microspheres (TheraSphere®; MDS Nordion,
Ottawa, Canada) are a primary treatment option for primary and secondary hepatic …

Objective To evaluate diffusion-weighted (DWI) magnetic resonance imaging (MRI) for
treatment prediction during chemoradiotherapy (CRT) of head and neck squamous cell …